Hemlibra 105mg Injection is a medicine used to prevent or reduce the frequency of bleeding episodes in both adult and pediatric patients with hemophilia A. This medicine helps the blood to clot normally, which helps prevent bleeding due to hemophilia A.
Hemlibra 105mg Injection is a medicine used to prevent or reduce the frequency of bleeding episodes in both adult and pediatric patients with hemophilia A. This medicine helps the blood to clot normally, which helps prevent bleeding due to hemophilia A.
Hemlibra 105mg Injection is generally given by a doctor or a nurse. Do not self-administer. The injection can be given in the thighs, upper arm, or in the abdomen. The dose and duration of the treatment will depend on your medical condition and how you respond to the treatment. Get the injection regularly for as long as the doctor has prescribed.
The most common side effects of this medicine are injection site reactions (such as pain, redness, or swelling), headache, and joint pain. If you experience any of these side effects or any other symptoms on receiving the injection, let your doctor know. They may be able to help on how to reduce the side effects.
Do not use Hemlibra 105mg Injection, if you have a known history of being allergic to any of the ingredients of this medicine. Let your doctor also know about your medical history and all the medicines you are taking. Women of childbearing potential should use contraception while on treatment with this medicine and for 6 months after the last dose. Pregnant or breastfeeding women should ask their doctors for advice before using this medicine.
Treatment of Haemophilia A
Your doctor or nurse will give you this medicine. Kindly do not self administer.
In people with hemophilia A who have low or missing factor VIII, the blood coagulation process cannot continue normally. Hemlibra 105mg Injection acts like a bridge, bringing factor IXa and factor X together to allow the blood coagulation process to continue without needing to replace factor VIII.
Q: What if you forget to take Hemlibra Injection?
A: If you miss a dose of Hemlibra 105mg Injection, inject the forgotten dose as soon as possible. However, if it is almost time for the next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Hemlibra 105mg Injection is a prescription medicine used for preventing bleeding episodes in adults and children, ages newborn and older, with hemophilia A.
Before using Hemlibra 105mg Injection, tell your doctor about all of your medical conditions, including if you are pregnant, plan to become pregnant, are breastfeeding, or plan to breastfeed.
Hemlibra 105mg Injection increases the potential for your blood to clot. You must inform your doctor before taking any other medication.
Your body may make antibodies against Hemlibra 105mg Injection, which may stop Hemlibra 105mg Injection from working properly. Contact your healthcare provider immediately if you notice that Hemlibra 105mg Injection has stopped working (eg, increase in bleeds).
In Treatment of Haemophilia A
Hemophilia A is a genetic condition where the blood does not clot properly because of a missing or faulty clotting protein called factor VIII (FVIII). People with hemophilia A experience prolonged bleeding, particularly after injuries or surgeries, which can be life-threatening if not adequately managed. Hemlibra 105mg Injection belongs to a class of medications known as monoclonal antibodies. In individuals with hemophilia A, this medicine can effectively reduce the frequency and severity of bleeding episodes, leading to better control over their bleeding and improves their overall quality of life.
Injection site reactions (pain, swelling, redness)
Joint pain
Headache
Alcohol:CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Hemlibra 105mg Injection. Please consult your doctor.
Pregnancy:CONSULT YOUR DOCTOR
Information regarding the use of Hemlibra 105mg Injection during pregnancy is not available. Please consult your doctor.
Breast feeding:CONSULT YOUR DOCTOR
Information regarding the use of Hemlibra 105mg Injection during breastfeeding is not available. Please consult your doctor.
Driving:SAFE
Hemlibra 105mg Injection does not usually affect your ability to drive.
Kidney:SAFE IF PRESCRIBED
Hemlibra 105mg Injection is safe to use in patients with kidney disease. No dose adjustment of Hemlibra 105mg Injection is recommended.
Liver:SAFE IF PRESCRIBED
Hemlibra 105mg Injection is safe to use in patients with liver disease. No dose adjustment of Hemlibra 105mg Injection is recommended.
1. Emicizumab [Prescribing Information]. South San Francisco, CA: Genentech, Inc.; 2023. [Accessed 21 Sep. 2023]. (online) Available from: View
2. Emicizumab [Summary of Product Characteristics]. Grenzach-Wyhlen, Germany: Roche Registration GmbH; 2022. [Accessed 21 Sep. 2023]. (online) Available from: View
3. Emicizumab injection [Product Monograph]. Mississauga, ON: Hoffmann-La Roche Limited; 2023. [Accessed 21 Sep. 2023]. (online) Available from: View
4. European Medicine Agency. Assessment report: Emicizumab. 2019. [Accessed 21 Sep. 2023]. (online) Available from: View
Hemlibra. How HEMLIBRA Works. [Accessed 25 Sep. 2023]. (online) Available from: View
Independent Platform: MedbeW.com is an independent aggregator. We are not affiliated with the manufacturer. Brand names are property of their respective owners and used here solely for identification.
Procurement & Availability: We do not store all the products listed on this website. This product will be procured from licensed distributors subject to availability. MedbeW acts as a facilitator to procure authentic medicines for you.
We would like to send you discount and latest offers .
